RS1 CAN PHARMACEUTICAL INDUSTRY USE REPS TO PROVIDE MEDICAL PRACTICE GUIDELINES? (MIGRAINE AND ASTHMA)
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63199-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)63199-3/fulltext
Title :
RS1 CAN PHARMACEUTICAL INDUSTRY USE REPS TO PROVIDE MEDICAL PRACTICE GUIDELINES? (MIGRAINE AND ASTHMA)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63199-3&doi=10.1016/S1098-3015(10)63199-3
First page :
Section Title :
Open access? :
No
Section Order :
50